- Inicio
- Análisis de app
- MCSAID
- MCSAID Vs. BifurcAID 3D
MCSAID vs BifurcAID 3D Uso & Estadísticas
MCSAID is an educational application dedicated to the topic of mechanical cardiocirculatory support for
patients with cardiogenic shock.
A basic section introduces the definitions and classifications of cardiogenic shock as well as some of the
common devices used for hemodynamic support in unstable patients.
There is an algorithm for helping understand the decision process depending on key clinical variables
such as cardiac output and PAPI. There are also several weaning and escalation algorithm.
A calculator section is available for some common hemodynamic variables used in MCS decision-making
and is available for quick-reference throughout the algorithm.
MCSAID is an educational application for medical professionals and is not intended for making medical diagnoses. Medical decisions must be made by licensed professionals with the entire context of a patient’s medical history. If you are seeking a medical diagnosis, contact your physician and if you are experiencing a medical emergency, call your local emergency medical services.
- App Store de Apple
- Gratis
- Medicina
Clasificación de tiendas
- -
BifurcAID 3D builds from the algorithm of BifurcAID and makes bifurcation lesion treatment even more easy to understand through 3D animations. Follow along with the detailed instructions for dedicated two-stent, provisional, and bailout techniques for left main and non-left main lesions.
- App Store de Apple
- Gratis
- Medicina
Clasificación de tiendas
- -
MCSAID frente a BifurcAID 3D: comparación de la clasificación
Comparar la tendencia de clasificación de MCSAID en los últimos 28 días con BifurcAID 3D
Rank
No hay datos disponibles
Comparación de las clasificaciones MCSAID frente a BifurcAID 3D por países
Comparar la tendencia de clasificación de MCSAID en los últimos 28 días con BifurcAID 3D
No hay datos para mostrar
Compara con cualquier sitio gracias a nuestra prueba gratuita
MCSAID VS.
BifurcAID 3D
12iciembre d, 2024